Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 50

1.

[Botulinum toxin type A in headache treatment : Established and experimental indications].

Gaul C, Holle-Lee D, Straube A.

Nervenarzt. 2016 Aug;87(8):853-9. doi: 10.1007/s00115-016-0138-5. German.

PMID:
27300190
2.

Botulinum Toxin Type a as a Therapeutic Agent against Headache and Related Disorders.

Luvisetto S, Gazerani P, Cianchetti C, Pavone F.

Toxins (Basel). 2015 Sep 23;7(9):3818-44. doi: 10.3390/toxins7093818. Review.

3.

Botulinum toxin and the treatment of headache: A clinical review.

Finkel AG.

Toxicon. 2015 Dec 1;107(Pt A):114-9. doi: 10.1016/j.toxicon.2015.09.008. Review.

PMID:
26365919
4.

Medical management of adult headache.

Freitag FG, Schloemer F.

Otolaryngol Clin North Am. 2014 Apr;47(2):221-37. doi: 10.1016/j.otc.2013.11.002. Review.

PMID:
24680490
5.

[Predictive factors of the response to treatment with onabotulinumtoxinA in refractory migraine].

Pagola I, Esteve-Belloch P, Palma JA, Luquin MR, Riverol M, Martinez-Vila E, Irimia P.

Rev Neurol. 2014 Mar 16;58(6):241-6. Spanish.

6.

Botulinum toxin A and headache treatment.

Gady J, Ferneini EM.

Conn Med. 2013 Mar;77(3):165-6. Review.

PMID:
23589955
7.

Managing and treating tension-type headache.

Freitag F.

Med Clin North Am. 2013 Mar;97(2):281-92. doi: 10.1016/j.mcna.2012.12.003. Review.

PMID:
23419626
8.

Botulinum toxin A for prophylactic treatment of migraine and tension headaches in adults: a meta-analysis.

Jackson JL, Kuriyama A, Hayashino Y.

JAMA. 2012 Apr 25;307(16):1736-45. doi: 10.1001/jama.2012.505.

PMID:
22535858
9.

Application of botulinum toxin to clinical therapy: advances and cautions.

Levy NS, Lowenthal DT.

Am J Ther. 2012 Jul;19(4):281-6. doi: 10.1097/MJT.0b013e3181e9b655.

PMID:
22481607
10.

Botox treatment for migraine and chronic daily headache in adolescents.

Chan VW, McCabe EJ, MacGregor DL.

J Neurosci Nurs. 2009 Oct;41(5):235-43.

PMID:
19835236
11.

Assessment: botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the therapeutics and technology assessment subcommittee of the american academy of neurology.

Mauskop A, Mathew N.

Neurology. 2009 Apr 14;72(15):1367; author reply 1367-8. doi: 10.1212/WNL.0b013e3181a53375. No abstract available. Erratum in: Neurology. 2009 Aug 18;73(7):573.

PMID:
19365063
12.

Botulinum toxin type-A (BOTOX) in the treatment of occipital neuralgia: a pilot study.

Taylor M, Silva S, Cottrell C.

Headache. 2008 Nov-Dec;48(10):1476-81. doi: 10.1111/j.1526-4610.2008.01089.x.

PMID:
19076646
13.

[Alternatives to beta blockers in preventive migraine treatment].

Evers S.

Nervenarzt. 2008 Oct;79(10):1135-6, 1138-40, 1142-3. doi: 10.1007/s00115-008-2522-2. Review. German.

PMID:
18806984
14.

Treating headaches with botulinum toxin.

Aguggia M.

Neurol Sci. 2008 May;29 Suppl 1:S137-9. doi: 10.1007/s10072-008-0905-6. Review.

PMID:
18545915
15.
16.

Botulinum toxin type A for the treatment of headache: why we say yes.

Ashkenazi A, Silberstein S.

Arch Neurol. 2008 Jan;65(1):146-9. doi: 10.1001/archneurol.2007.20. Review. No abstract available.

PMID:
18195155
17.
18.

Botulinum toxin type A for the treatment of nummular headache: four case studies.

Mathew NT, Kailasam J, Meadors L.

Headache. 2008 Mar;48(3):442-7.

PMID:
18028377
19.

Evidence based medicine on the use of botulinum toxin for headache disorders.

Schulte-Mattler WJ, Leinisch E.

J Neural Transm (Vienna). 2008;115(4):647-51. Review.

PMID:
17994180
20.

Botulinum toxin type A in refractory chronic migraine: an open-label trial.

Menezes C, Rodrigues B, Magalhães E, Melo A.

Arq Neuropsiquiatr. 2007 Sep;65(3A):596-8.

Items per page

Supplemental Content

Loading ...
Support Center